Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Inovio Pharmaceuticals, Inc. (INO) had Return on Investments of -137.55% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-6.01M |
|
-- |
|
-- |
|
$18.62M |
|
$-18.62M |
|
$12.61M |
|
$-6.01M |
|
$-6.01M |
|
$-6.01M |
|
$-6.01M |
|
$-6.01M |
|
$-6.01M |
|
$-18.62M |
|
$-17.87M |
|
81.62M |
|
81.62M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$39.91M |
|
$1.89M |
|
$9.48M |
|
$49.39M |
|
$39.92M |
|
-- |
|
$5.10M |
|
$45.02M |
|
$4.37M |
|
$4.37M |
|
$4.37M |
|
82.34M |
|
| Cash Flow Statement Financials | |
$-39.64M |
|
$8.78M |
|
$18.11M |
|
$44.27M |
|
$31.53M |
|
$-12.75M |
|
$1.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-39.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-137.55% |
|
-137.55% |
|
-12.17% |
|
|
Return on Investments |
-137.55% |
$0.05 |
|
$-0.49 |
|
$-0.49 |
|